new post
StocksRunner logo
mail
search
 
menu
 
Fulcrum Therapeutics
$11.58
-3.58%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

FULC Stock Analysis & IQ Rating | Fulcrum Therapeutics

 
 
 

FULC

 

Fulcrum Therapeutics

$11.58

 
-$0.43 | -3.58%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$15.74
 
 
MKT CAP
$763.94M
 
52W Low
$2.32
 
 
VOL
$444.76K
 
P/E Ratio
N/A
 
 
AVG VOL
$2.04M
 
RSI
50.77
 
 
TREND
Uptrend
 
 
 

BQ Stock IQ

 
lock  Login to see Fulcrum Therapeutics (FULC) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

FULC Target Price

 
 
 

Strengths

 
 

FULC Rewards

 Earnings are forecast to grow

FULC Rewards

 Upgraded on attractively valued

FULC Rewards

 Trading below its fair value

 
 

FULC Price Performance

 
 

$9.87   (+17.33%)

$9.51   (+21.77%)

$6.94   (+66.86%)

$4.06   (+185.22%)

 
 
1year
6month
3month
1month
 

FULC Risk Level

 
 

FULC has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 Beta greater than 1.0

 High volatilty

 
 
FULC Risk Level
Extreme
LOW
HIGH
 

FULC Analysts Opinion

 

FULC overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

FULC Earnings Sentiment

 Below analyst estimate

 
 

Rating

×
 

Rating

 

FULC Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

FULC Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

FULC Future Sentiment

 Earnings are forecast to grow

FULC Future Sentiment

 Trading below its fair value

 
 

FULC Analysts Opinion

FULC Analysts opinion is negative but has improved from the past 3 months

 

FULC Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
100%
100%
 

FULC Street Sentiment 

FULC Street Sentiment is extremely bullish and have negative views on the near-term outlook

 

FULC Performance Sentiment

 
Sentiments overview associated with FULC events and the stock performance.
 
 
100%
0%
Positive
Negative
6 out of 6
events present
0 out of 6
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$12.01
 
Resistance
Price
 
$10.14
 
 
Current Price Range
 
$14.60
 
 
Show methods +
 
 
Linked to FULC
IQ
Close Price
Change
 

SNY

3.74

48.47

+0.23%

 

PFE

3.72

25.09

+0.24%

 

NVO

4.04

52.40

-0.30%

 
 
 
FULC Latest Analysis +
 
 
FAQ About FULC Stock Insights
 

What is FULC current stock price?

What are FULC stock strengths?

What is FULC Risk Level?

What is FULC market cap and volume?

What is FULC current Stock IQ?

Should I buy FULC stock right now?

Is FULC a Strong Buy right now?

What does a 'Strong Buy' rating mean for FULC?

What does a 'Strong Sell' rating mean for FULC?

What factors influence FULC's Stock IQ?

 
 
StocksRunner

Explore our FULC Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FULC Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our FULC Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 
 

FULC

 

Fulcrum Therapeutics

 
 

Current Price

 

$11.58

 
-$0.43 | -3.58%
 
 
52W High
$15.74
 
 
MKT CAP
$763.94M
 
52W Low
$2.32
 
 
VOL
$444.76K
 
P/E Ratio
N/A
 
 
AVG VOL
$2.04M
 
RSI
50.77
 
 
TREND
Uptrend
 
 
 
Set Alerts
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

FULC Rewards

 Earnings are forecast to grow

FULC Rewards

 Upgraded on attractively valued

FULC Rewards

 Trading below its fair value

 
 
 

Linked to FULC

 
 
 
Symbol
IQ
Close
Change
 

SNY

3.74

48.47

+0.23%

 

PFE

3.72

25.09

+0.24%

 

NVO

4.04

52.40

-0.30%

 
 
 
 
 
user
 
 
 
 

FULC Price Performance

 
 

$9.87   (+17.33%)

$9.51   (+21.77%)

$6.94   (+66.86%)

$4.06   (+185.22%)

 
 
1year
6month
3month
1month
 

FULC Analysts Opinion

 

FULC Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

FULC Earnings Sentiment

 Below analyst estimate

 
 

Rating

×
 

Rating

 

FULC Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

FULC Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 
 

Future

×
 

Future

 

FULC Future Sentiment

 Earnings are forecast to grow

FULC Future Sentiment

 Trading below its fair value

 
 

FULC Analysts Opinion

FULC Analysts opinion is negative but has improved from the past 3 months

 

FULC Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
100%
100%
 

FULC Street Sentiment 

FULC Street Sentiment is extremely bullish and have negative views on the near-term outlook

 

FULC Risk Level

 
 

FULC has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 

 Beta greater than 1.0

 High volatilty

 
 
FULC Risk Level
Extreme
LOW
HIGH
 
FULC Performance Sentiment
 
Sentiments overview associated with FULC events and the stock performance.
 
 
100%
0%
Positive
Negative
6 out of 6
events present
0 out of 6
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$12.01
 
Resistance
Price
 
$10.14
 
 
Current Price Range
 
$14.60
 
 
Show methods +
 
 
 
 
 
 

FULC Stock IQ

 
 
 
lock  Login to unlock Fulcrum Therapeutics (FULC) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

FULC Latest Analysis

 
 
 

Truist Securities Maintains Fulcrum Therapeutics (FULC) Buy Recommendation. Fintel reports that on December 11 2025 Truist Securities maintained coverage of Fulcrum Therapeutics (NasdaqGM:FULC) with a Buy recommendation. Analyst Price Forecast Suggests 14.26% Upside

 

Fri Dec 12, 2025

$13.00 | +1.56%
 
Rating

Fulcrum Therapeutics announces pricing of upsized $175M public offering of common stock pre-funded warrants.

 

Wed Dec 10, 2025

$13.80 | -5.48%
 
Activity

Fulcrum Therapeutics announces proposed $150.0 million public offering of common stock.

 

Mon Dec 8, 2025

$12.99 | +45.96%
 
Activity

Fulcrum Therapeutics Stock Rally Ignited By Promising Sickle Cell Results. ) stock is surging on Monday after the company released initial results from the ongoing 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir .“.We are highly encouraged by these initial data from the 20 mg cohort which show clear evidence of a dose-response and build on the strong profile established with the 12 mg cohort”. said Alex Sapir Fulcrum’.s President and CEO.Mean absolute fetal hemoglobin

 

Mon Dec 8, 2025

$12.99 | +45.96%
 
Activity
Momentum

Fulcrum Therapeutics shares rise after positive phase 1b sickle cell trial results.

 

Mon Dec 8, 2025

$12.99 | +45.96%
 
Activity
 
 
 
 
 
StocksRunner

Discover FULC Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of FULC. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our FULC Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

FULC Stock trends

FULC Stock performance

FULC Stock analysis

FULC investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

FULC Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing FULC

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing FULC

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.